Securities code: 300813 securities abbreviation: Zhejiangtailin Bioengineering Co.Ltd(300813) Announcement No.: 2022-001
Zhejiangtailin Bioengineering Co.Ltd(300813)
Issue convertible corporate bonds to unspecified objects
Announcement of issuance results
Sponsor (lead underwriter): China Greatwall Securities Co.Ltd(002939)
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Zhejiangtailin Bioengineering Co.Ltd(300813) (hereinafter referred to as ” Zhejiangtailin Bioengineering Co.Ltd(300813) “, “issuer” or “company”) has obtained the consent of China Securities Regulatory Commission (hereinafter referred to as “CSRC”) zjxk [2021] No. 2258 to register for issuing convertible corporate bonds (hereinafter referred to as “convertible bonds”) to unspecified objects. China Greatwall Securities Co.Ltd(002939) (hereinafter referred to as ” China Greatwall Securities Co.Ltd(002939) ” or “sponsor (lead underwriter)”) is the sponsor (lead underwriter) of this offering.
This issuance of RMB 21 million convertible bonds, with a face value of RMB 100 each, totaling 2100000, is issued at face value. The convertible corporate bonds issued this time are referred to as “Tailin convertible bonds” for short, and the bond code is “123135”. The convertible bonds issued to unspecified objects shall be placed preferentially to the original shareholders registered by China Securities Depository and Clearing Co., Ltd. Shenzhen Branch (hereinafter referred to as “CSDCC Shenzhen Branch” and “registration company”) after the closing of the market on the equity registration date (December 27, 2021, t-1), The balance after the preferential placement of the original shareholders (including the part abandoned by the original shareholders) is issued to the public investors online through the trading system of Shenzhen Stock Exchange (hereinafter referred to as “Shenzhen Stock Exchange”).
1、 Priority placement results of original shareholders
The payment for the preferred placement of the original shareholders of this offering has been completed on December 28, 2021 (t day). A total of 1642651 talin convertible bonds, i.e. 164265100 yuan, were preferentially placed to the original shareholders, accounting for 78.22% of the total issued.
2、 Online lottery payment
The online subscription and payment of the balance after the preferential placement of the original shareholders (including the preferential placement abandoned by the original shareholders) has been completed on December 30, 2021 (T + 2). According to the data provided by Shenzhen Stock Exchange and China Clearing Shenzhen Branch, the sponsor (lead underwriter) made statistics on the final subscription of this online issuance of convertible bonds, and the results are as follows:
1. Number of convertible bonds subscribed by online investors (piece): 446670
2. Subscription amount paid by online investors (yuan): 44667000.00
3. Number of convertible bonds waived by online investors (PCS): 10670
4. Subscription amount waived by online investors (yuan): 1067000.00
3、 Underwriting by the sponsor (lead underwriter)
According to the underwriting agreement, the convertible bonds that the online investors give up the subscription shall be underwritten in full by the sponsor (lead underwriter). In addition, the Zhejiangtailin Bioengineering Co.Ltd(300813) announcement on issuing convertible corporate bonds to unspecified objects stipulates that each piece of convertible corporate bonds shall be preferentially placed to the original shareholders as one subscription unit, and each 10 pieces of online subscription shall be one subscription unit. Therefore, the balance of 9 pieces shall be underwritten by the sponsor (lead underwriter).
The total number of Tailin convertible bonds underwritten by the recommendation institution (lead underwriter) is 10679, the underwriting amount is 1067900.00 yuan, and the underwriting proportion is 0.51%.
On January 4, 2022 (T + 4), the recommendation institution (lead underwriter) transferred the subscription funds of convertible bonds to the issuer after deducting the underwriting recommendation fees according to the underwriting agreement. The issuer submitted a registration application to CSDCC Shenzhen Branch and registered the underwritten convertible bonds to the securities account designated by the recommendation institution (lead underwriter).
4、 Contact information of sponsor (lead underwriter)
If you have any questions about the issuance results announced in this announcement, please contact the sponsor (lead underwriter) of this issuance. Contact details are as follows:
Sponsor (lead underwriter): China Greatwall Securities Co.Ltd(002939)
Address: 15 / F, South Tower, energy building, No. 2026, Jintian Road, Futian street, Futian District, Shenzhen
Tel: 0755-23930449, 0755-889914
Contact: Capital Market Department of investment banking division
Issuer: Zhejiangtailin Bioengineering Co.Ltd(300813) sponsor (lead underwriter): China Greatwall Securities Co.Ltd(002939) January 4, 2022
(there is no text on this page, which is the seal page of the announcement on the issuance results of Zhejiangtailin Bioengineering Co.Ltd(300813) convertible corporate bonds to unspecified objects)
Issuer: Zhejiangtailin Bioengineering Co.Ltd(300813) mm / DD / yyyy (there is no text on this page, which is the seal page of the announcement on the issuance results of Zhejiangtailin Bioengineering Co.Ltd(300813) issuing convertible corporate bonds to unspecified objects)
Sponsor (lead underwriter): China Greatwall Securities Co.Ltd(002939) mm / DD / yy
